echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > CMI: The effect of hydroxychloroquine alone or combined with azithromycin on the mortality of COVID-19 patients

    CMI: The effect of hydroxychloroquine alone or combined with azithromycin on the mortality of COVID-19 patients

    • Last Update: 2021-09-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    BACKGROUND: quinoline hydroxychloroquine with or without azithromycin have been widely used to treat 2019 coronavirus (COVID-19), had on in early of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) also have in vitro antiviral effect
    .

    Quinolin hydroxychloroquine with or without azithromycin have been widely used to treat 2019 coronavirus (COVID-19), had on in early of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) also have in vitro antiviral effect
    .


    Purpose: A meta-analysis to compare the mortality of patients with hydroxychloroquine with or without azithromycin and standard treatment
    .


    The subjects of the study are patients with confirmed COVID-19, aged ≥18 years


    Results: The preliminary search yielded 839 articles, 29 of which met our inclusion criteria
    .


    With the exception of one study, all studies were conducted on hospitalized patients and evaluated the therapeutic effect of hydroxychloroquine with or without azithromycin


    Table According to the ISARIC WHO CCP-UK cohort, assuming a hospital mortality rate of 26% in the UK, the relative risk and risk difference of hydroxychloroquine with or without azithromycin-related mortality

    Table According to the ISARIC WHO CCP-UK cohort, assuming a hospital mortality rate of 26% in the UK, the relative risk and risk difference of hydroxychloroquine with or without azithromycin-related mortality

    Conclusion: Among hospitalized COVID19 patients, hydroxychloroquine alone cannot reduce the mortality rate, but the combined use of hydroxychloroquine and azithromycin can significantly increase the mortality rate
    .

    Among hospitalized COVID19 patients, the use of hydroxychloroquine alone does not reduce the mortality rate, but the combined use of hydroxychloroquine and azithromycin can significantly increase the mortality rate
    .


    Original source

     Fiolet T, Guihur A, Rebeaud ME,Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.


     Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.